thrombopoietin mimetics (Axys)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namethrombopoietin mimetics (Axys)
Drug Alias Namethrombopoietin mimetics (Arris)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth factor receptors modulators
TargetsGrowth factor receptors
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArris Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArris Pharmaceutical CorpCelera
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A